Physician profile
James T Sable
NPI 1881866671
$4,732.10
in general payments reported to CMS, 2019-2025
20 companies · $62.87 in 2025
The $62.87 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,651 · 2020: $170 · 2021: $167 · 2022: $52.79 · 2023: $208 · 2024: $420 · 2025: $62.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $3,391.32 | 2019 | |
| Medtronic, INC. | $208.99 | 2024 | Synchromedii, Intellis Adaptivestim |
| Lilly USA, LLC | $187.13 | 2019-2024 | Reyvow, Emgality |
| Amgen INC. | $148.00 | 2019-2021 | |
| Abbvie INC. | $137.80 | 2021-2025 | Qulipta |
| Nevro Corp. | $124.83 | 2019-2024 | Senza |
| Pfizer INC. | $79.32 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $73.09 | 2019-2023 | Belbuca |
| Grt US Holding, INC. | $61.28 | 2021-2022 | |
| Averitas Pharma INC. | $57.03 | 2023 | Qutenza |
| Abbott Laboratories | $42.92 | 2019-2023 | Proclaim |
| Almatica Pharma LLC | $40.40 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $32.38 | 2021 | |
| Boston Scientific Corporation | $31.08 | 2019-2025 | General - Pain Management |
| Assertio Therapeutics, INC. | $29.66 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.21 | 2023 | Vyepti |
| Biohaven Pharmaceuticals, INC. | $18.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.07 | 2019 | |
| Pacira Therapeutics, INC. | $16.25 | 2019 | |
| Mdd US Operations, LLC | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.